StonvexLoading…
StonvexStonvexStonvexCore line items from UTHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $829.38M | $781.50M | $3.18B | $2.39B | $1.59B |
Operating Income | Not available | $325.80M | $1.49B | $1.14B | $747.30M |
Net Income | Not available | $274.90M | $1.33B | $970.40M | $631.70M |
EPS (Diluted) | $7.15 | $5.82 | $27.86 | $20.17 | $13.02 |
Total Assets | Not available | $6.71B | $7.88B | $7.35B | $7.91B |
Total Liabilities | Not available | $813.10M | $783.80M | $760.90M | $734.40M |
Cash & Equivalents | Not available | $1.28B | $1.56B | $1.34B | $1.59B |
Free Cash Flow OCF − CapEx | Not available | $362.50M | $1.04B | $867.40M | $515.80M |
Shares Outstanding | Not available | 42.16M | 43.64M | 42.90M | 45.22M |